Literature DB >> 8720193

Testing susceptibility of Candida species to fluconazole and itraconazole using the microdilution assay.

M Seibold1, E Werner.   

Abstract

A microdilution system was established for testing the susceptibility of Candida species to fluconazole and itraconazole. The assay used a sodium phosphate-buffered (0.1 mol l-1) Casitone/glucose medium (pH 7.2) supplemented with potassium, iron, magnesium, trace elements and vitamins. Tests were read photometrically after 24 h, and the minimum inhibitory concentration (MIC) was defined as the IC90. In nearly all strains sharp end points were observed. The MICs against Candida species without any known pre-exposure to azoles were found to range from 0.2 to 1.56 micrograms ml-1 for fluconazole and from 2.3 to 12 ng ml-1 for intraconazole. For strains from candidosis patients refractory to treatment with fluconazole the MICs of fluconazole ranged from 6.25 to 100 micrograms ml-1, while those for itraconazole varied between 12 and > 450 ng ml-1. The strains did not respond congruent to both azoles. A similar disparity of the MICs was observed with Candida tropicalis and Candida krusei. The unusually low MICs of itraconazole were attained because (1) the dilution series was prepared from a preformed (concentrated) dilution series in 75% dimethylsulphoxide and not directly by serial dilution in the broth and (2) the incubation was performed in microtitre plates made of quartz glass rather than in the generally used polystyrene microtitre plates.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8720193     DOI: 10.1111/j.1439-0507.1995.tb00017.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  2 in total

1.  Human deep tissue infection with an entomopathogenic Beauveria species.

Authors:  Markus Oliver Henke; G Sybren De Hoog; Uwe Gross; Gisbert Zimmermann; Doris Kraemer; Michael Weig
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

2.  Disseminated Neocosmospora vasinfecta infection in a patient with acute nonlymphocytic leukemia.

Authors:  O A Cornely; J Chemnitz; H G Brochhagen; K Lemmer; H Schütt; D Söhngen; P Staib; C Wickenhauser; V Diehl; K Tintelnot
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.